Andrew Witty and Ned Sharpless Join Durham's Hatteras Venture Partners
Former GSK CEO Andrew Witty and ex-NCI director Ned Sharpless have joined Durham-based Hatteras Venture Partners, which closed a record $200M raise and scored a $2.45B Bayer exit.